Eli Lilly is just weeks away from launching ... which was approved by the MHRA last year, the Mounjaro KwikPen can be used to treat adults with type 2 diabetes and for weight management in adult ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

The Nasdaq slid 4%, its biggest single-day percentage drop since September 2022. The S&P 500 closed below its 200-day moving average, a closely watched support level, for the first time since ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Diabetes describes a group of metabolic diseases characterized by high blood sugar levels. Diabetes can be caused by the pancreas not producing insulin (type 1 diabetes) or by insulin resistance ...

Pre-market: 4:27:02 am GMT-4 Loading Chart for LLY ...